MedPath

BILAXTEN 20 mg COMPRIMIDOS

BILAXTEN 20 mg COMPRIMIDOS

Commercialized
Register Number

5341508

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Sep 6, 2018

Dosage Form

COMPRIMIDO

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number5341508
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

BILASTINAActive
Quantity: 20 mg
Name: BILASTINA

ATC CLASSIFICATION (3)

R06A
R06AX
R06AX29

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.